Journal
JAPANESE JOURNAL OF CLINICAL ONCOLOGY
Volume 38, Issue 7, Pages 501-503Publisher
OXFORD UNIV PRESS
DOI: 10.1093/jjco/hyn055
Keywords
gastric cancer; laparoscopy assisted gastrectomy; phase II study
Categories
Ask authors/readers for more resources
A phase II trial was started in Japan to evaluate the safety of laparoscopy-assisted distal gastrectomy (LADG) for clinical stage I gastric cancer. A total of 170 patients will be enrolled in this study by expert surgeons for laparoscopy from 16 institutions over 1 year. The primary endpoint is incidence of anastomotic leak and pancreatic fistula. The secondary endpoints are overall survival, relapse-free survival, proportion of completion of LADG, proportion of conversion from LADG to open gastrectomy, surgical morbidity and short-term clinical outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available